PATENT CLAIM ANALYSIS

Application Number: 16002285
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "452000"]

Abstract:
Delayed sustained release pharmaceutical compositions that provide therapeutic effects over extended periods of time (i.e., 14-16 hours).

Claim (Index 7):
The pharmaceutical composition of  claim 6 , wherein the at least one amphetamine salt is dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, amphetamine sulfate, or mixtures thereof, and the at least one amphetamine salt is present in an amount from 12.5 mg to 75 mg.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11383066', '14498130', '15069734', '14255529', '14710453']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7507176225151899
- 35 USC 102 Novelty (BERT): 0.5329839979533085
- Combined Prediction Score: 0.7289442600590017
- Mean Citation Score: 317.6499560000001
- Max Citation Score: 356.2013
- Similarity Product: 246.47997332155705

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test